Value Aligned Research Advisors LLC Has $115.48 Million Stock Holdings in Core Scientific, Inc. $CORZ

Value Aligned Research Advisors LLC trimmed its holdings in shares of Core Scientific, Inc. (NASDAQ:CORZ) by 4.6% in the first quarter, Holdings Channel.com reports. The firm owned 7,718,962 shares of the company’s stock after selling 370,735 shares during the quarter. Value Aligned Research Advisors LLC’s holdings in Core Scientific were worth $115,476,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. AQR Capital Management LLC lifted its stake in Core Scientific by 106.1% in the first quarter. AQR Capital Management LLC now owns 283,432 shares of the company’s stock valued at $2,052,000 after buying an additional 145,905 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Core Scientific by 180.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,109,387 shares of the company’s stock worth $8,032,000 after acquiring an additional 714,388 shares in the last quarter. Cetera Investment Advisers increased its position in shares of Core Scientific by 200.0% during the second quarter. Cetera Investment Advisers now owns 38,819 shares of the company’s stock worth $663,000 after acquiring an additional 25,878 shares in the last quarter. Franklin Resources Inc. acquired a new stake in shares of Core Scientific during the second quarter worth $181,000. Finally, Russell Investments Group Ltd. raised its holdings in shares of Core Scientific by 61.9% during the second quarter. Russell Investments Group Ltd. now owns 3,942 shares of the company’s stock worth $67,000 after acquiring an additional 1,507 shares during the period.

Core Scientific Stock Up 0.0%

NASDAQ CORZ opened at $20.75 on Wednesday. Core Scientific, Inc. has a 12-month low of $12.60 and a 12-month high of $30.46. The company has a market capitalization of $6.60 billion, a PE ratio of -18.20 and a beta of 5.50. The firm’s 50 day moving average is $25.32 and its 200-day moving average is $20.77.

Core Scientific (NASDAQ:CORZ) last announced its quarterly earnings data on Tuesday, July 28th. The company reported ($3.32) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($3.26). The firm had revenue of $164.20 million for the quarter, compared to analyst estimates of $144.83 million. As a group, sell-side analysts expect that Core Scientific, Inc. will post 0.08 EPS for the current year.

Key Core Scientific News

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: AMD partnership creates significant long-term revenue potential. AMD will secure up to 2.5 gigawatts of Core Scientific data-center capacity for AI deployments. The initial 530-megawatt rollout across five sites is backed by 15-year agreements and could generate approximately $14 billion in potential base contracted revenue. AMD also received warrants to purchase 30 million CORZ shares at $23.47, with vesting tied to successful capacity deployment. Reuters AMD infrastructure partnership article
• Positive Sentiment: Colocation growth reinforces the AI pivot. Second-quarter revenue reached $164.2 million, while colocation revenue reportedly climbed to $136.7 million from $10.6 million a year earlier. The company said adjusted EBITDA was $41.1 million, suggesting improving operating performance despite reported accounting losses. Core Scientific second-quarter results
• Positive Sentiment: Analyst support and bullish options activity added momentum. Needham reaffirmed a Buy rating with a $29 price target, while BTIG maintained Buy with a $38 target. Call-option volume was approximately 55% above its average daily level, indicating increased speculative interest, though options activity is not a guarantee of future gains.
• Neutral Sentiment: Reported earnings contained conflicting signals. Core Scientific posted a $3.32-per-share quarterly GAAP loss, far below consensus, but another earnings measure cited by Zacks showed adjusted EPS of $0.18 versus expectations for a $0.02 loss. The GAAP deficit was reportedly driven largely by noncash warrant fair-value adjustments.
• Negative Sentiment: Execution, dilution and spending risks remain material. Core Scientific incurred approximately $797.5 million in quarterly capital expenditures to convert mining sites for high-density computing. The AMD warrants could dilute shareholders, while an insider’s sale of 10,000 shares and a recent KBW downgrade to Market Perform may temper enthusiasm.

Wall Street Analysts Forecast Growth

CORZ has been the subject of a number of research analyst reports. Freedom Capital raised shares of Core Scientific to a “hold” rating in a research note on Monday, June 15th. Canaccord Genuity Group set a $30.00 price target on Core Scientific in a research note on Friday, May 8th. Jefferies Financial Group lifted their price target on Core Scientific from $24.00 to $37.00 and gave the company a “buy” rating in a research note on Thursday, May 14th. B. Riley Financial boosted their price target on Core Scientific from $30.00 to $33.00 and gave the company a “buy” rating in a report on Wednesday, May 27th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating and set a $32.00 price objective on shares of Core Scientific in a research report on Wednesday, June 3rd. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $30.39.

Insider Transactions at Core Scientific

In other Core Scientific news, insider Todd M. Duchene sold 10,000 shares of the business’s stock in a transaction dated Monday, July 20th. The shares were sold at an average price of $22.30, for a total transaction of $223,000.00. Following the sale, the insider directly owned 1,999,101 shares of the company’s stock, valued at $44,579,952.30. The trade was a 0.50% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. In the last quarter, insiders have sold 80,000 shares of company stock valued at $2,025,400. 1.70% of the stock is currently owned by insiders.

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.